SCHEMBL4958784

SCHEMBL4958784

CCCCCCCCCCCCCCCCC(CC(O)CO)C(=O)OCCOC(=O)CCCCCCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.58
DUSP3 P51452 1/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
LMNA P02545 1/20 0.58
DGKA P23743 2/20 0.57
CNR2 P34972 2/20 0.49
MAPT P10636 1/20 0.47
ENPP2 Q13822 4/20 0.46
TRPV1 Q8NER1 1/20 0.46
LPAR6 P43657 1/20 0.46
LPAR1 Q92633 1/20 0.46
LPAR4 Q99677 1/20 0.46
LPAR5 Q9H1C0 1/20 0.46
LPAR2 Q9HBW0 1/20 0.46
LPAR3 Q9UBY5 1/20 0.46
PRKCA P17252 1/20 0.46
PRKCE Q02156 1/20 0.46
PRKCQ Q04759 1/20 0.46
PRKCD Q05655 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3483988 1.00 KDM4E (0.58) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL3483583 1.00 KDM4E (0.58) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL14778639 0.87 USP2 (0.47) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL738730 0.87 USP2 (0.47) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL7539769 0.87 USP2 (0.47) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL20917644 0.87 USP2 (0.47) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL1173137 0.87 USP2 (0.47) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL16752509 0.86 MEN1 (0.57) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL21247439 0.86 USP2 (0.46) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL5570188 0.86 KDM4E (0.45) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080031834-A1 Cosmetic Compositions REVLON CONSUMER PRODUCTS CORPORATION (US) 2008-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080031834-A1 Cosmetic Compositions DPM1, DDT, DUS2 KDM4E 752/4885DUSP3 372/4885MEN1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.